The future of cancer drug mechanisms lies in personalized medicine, where treatments are tailored to the genetic makeup of the individual's cancer. Advances in [genomic sequencing](#) and biomarker identification are paving the way for more precise and effective therapies. Additionally, the combination of traditional treatments with novel approaches such as [CRISPR-based therapies](#) and [nanotechnology](#) holds promise for revolutionizing cancer treatment.
